Zolmitriptan - Migraine (acute)
You are here : Home > Formulary Search > Zolmitriptan - Migraine (acute)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Nasal spray
- Tablets
Formulary Status :
Restrictions / Comments :
Preferred
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Zolmitriptan
Indication :
Migraine (acute)
Group Name :
Keywords :
Triptans, acute migraine, migraine treatment
Brand Names Include :
Zomig
Important Information :
Prescribe generically
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Zolmitriptan is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Migraine (acute).
Committee Recommendations (2)
GENERIC Zolmitriptan has been considered by the PCN and has been assigned a GREEN 1st line traffic light status. NOTE - the branded product, Zomig, was considered BLACK at the PCN in May 2017.
Zolmitriptan/ Rizatriptan orodispersible tablets should be considered as a suitable first line treatment for patients when there are difficulties in swallowing the solid dose formulations or the patient has difficulties with nausea and vomiting.
UPDATED: The PCN recommends that sumatriptan, zolmitriptan, rizatriptan and naratriptan should be considered as first line triptans where clinically appropriate and should be prescribed generically.